Spring til indhold.
Forside

Store Vildmose (lokale N0.124)

The Department of Clinical Medicine

PhD defense by Inge Agnete Gerlach Brandt

The Department of Clinical Medicine, Aalborg University and Aalborg University Hospital are pleased to invite to PhD defense by Inge Agnete Gerlach Brandt who will defend the thesis entitled: "Bone Quality in Persons with Type 1 Diabetes: Clinical Measures and Predictors of Bone Disease"

Store Vildmose (lokale N0.124)

Diabeteshuset, Hospitalsbyen 4
Nyt Aalborg Universitetshospital
9260 Gistrup

  • 09.12.2024 Kl. 13:00 - 16:00

  • After the defense there will be held a reception. All are welcome.

  • English

  • On location

Store Vildmose (lokale N0.124)

Diabeteshuset, Hospitalsbyen 4
Nyt Aalborg Universitetshospital
9260 Gistrup

09.12.2024 Kl. 13:00 - 16:0009.12.2024 Kl. 13:00 - 16:00

English

On location

The Department of Clinical Medicine

PhD defense by Inge Agnete Gerlach Brandt

The Department of Clinical Medicine, Aalborg University and Aalborg University Hospital are pleased to invite to PhD defense by Inge Agnete Gerlach Brandt who will defend the thesis entitled: "Bone Quality in Persons with Type 1 Diabetes: Clinical Measures and Predictors of Bone Disease"

Store Vildmose (lokale N0.124)

Diabeteshuset, Hospitalsbyen 4
Nyt Aalborg Universitetshospital
9260 Gistrup

  • 09.12.2024 Kl. 13:00 - 16:00

  • After the defense there will be held a reception. All are welcome.

  • English

  • On location

Store Vildmose (lokale N0.124)

Diabeteshuset, Hospitalsbyen 4
Nyt Aalborg Universitetshospital
9260 Gistrup

09.12.2024 Kl. 13:00 - 16:0009.12.2024 Kl. 13:00 - 16:00

English

On location

About the PhD thesis

Diabetes-related osteoporosis is a lesser-known complication of type 1 diabetes. Previous clinical and epidemiological studies have shown decreased bone turnover and bone mineral density (BMD) as well as impaired microstructure and accumulation of advanced glycation end-products (AGEs) in individuals with type 1 diabetes.

The aim of this thesis is to characterize the bones of adults with type 1 diabetes, investigate the relationship between muscle and bone in individuals with type 1 diabetes, and discuss whether risk factors such as autonomic neuropathy and accumulation of AGEs may pre-dict low bone quality in type 1 diabetes.

The above is elucidated through clinical studies. The results contrib-ute to describing a type 1 diabetes bone phenotype by confirming a microstructural difference between bones in individuals with and with-out type 1 diabetes. The volumetric mineral density in trabecular bone was decreased in individuals with type 1 diabetes. In addition, decreased cortical bone thickness was observed in the distal radius and tibia. Muscle mass and strength were positively correlated with bone mineral density in both individuals with and without type 1 diabetes, and no differences in muscle mass and strength were ob-served between groups. Finally, the results showed that higher levels of AGE accumulation measured by skin autofluorescence were asso-ciated with lower BMD and trabecular bone score (TBS) and could potentially contribute to the overall assessment of fracture risk in indi-viduals with type 1 diabetes.

Attendees

in the defence
Supervisors
  • Peter Vestergaard, MD, MSc, Steno Diabetes Center North Denmark, Aalborg University
  • Morten Frost Nielsen, MD, clinical professor, Novo Nordisk, Denmark
  • Torben Harsløf, MD, PhD, Aarhus University Hospital, Denmark
  • Stinus Gadegaard Hansen, MD, PhD, Odense University Hospital, Svendborg, Denmark
  • Rikke Viggers, MD, PHD, Aalborg University Hospital, Denmark
  • Nicklas Højgaard-Hessellund Rasmussen, MD, PhD, North Denmark Regional Hospital, Hjørring, Denmark
Assessment committee
  • Henrik Nielsen (chair), clinical professor, Aalborg University, Denmark
  • Caroline Wyers, PhD, VieCuri Medical Center, The Netherlands
  • Søren Nielsen, clinical professor, Steno Diabetes Center Aarhus, Denmark

Contact